David W. Grainger

A co-founder of the Company serves as its Chief Scientific Officer and a member of its Board of Directors. Dr. Grainger is a Distinguished Professor and Presidential Endowed Chair of the Department of Pharmaceutics and Pharmaceutical Chemistry, and a Professor of Bioengineering, at the University of Utah. He serves as a scientific advisor to the AO Foundation in Switzerland and the affiliated Synthes Orthopaedics, the leader in orthopedic trauma devices, before its 2011 acquisition by Johnson & Johnson’s DePuy orthopedics division. Dr. Grainger’s research is focused on biomedical polymer-based drug delivery and implanted medical device innovation. Prior to joining the University of Utah faculty in 2006, Dr. Grainger held faculty positions at Colorado State University and Oregon Health Sciences University. He has helped to found three biomedical technology companies, sits on the scientific advisory boards of four companies, and actively consults internationally with industries in applications of materials in biotechnologies and medicine. Dr. Grainger graduated from Dartmouth College with a B.A. in Engineering and Chemistry, received a Ph.D. in Pharmaceutics from the University of Utah, and was a Humboldt Postdoctoral Fellow at the University of Mainz, Germany early in his career.